Article

Inserts using femtosecond laser less traumatic, more accurate than conventional method

The IntraLase femtosecond laser (IntraLase) allows less traumatic implantation of micro-thin prescription inserts (Intacs, Addition Technology) compared with the conventional mechanical method of implantation.

Paris—The IntraLase femtosecond laser (IntraLase) allows less traumatic implantation of micro-thin prescription inserts (Intacs, Addition Technology) compared with the conventional mechanical method of implantation.

The procedure results in high patient satisfaction and it is easy to learn and to perform, said Yaron Rabinowitz, MD, of Cedars-Sinai Medical Center, Los Angeles. Dr. Rabinowitz demonstrated at the European Society of Cataract and Refractive Surgeons annual meeting how the IntraLase femtosecond laser made accurate and reproducible intralamellar channels in the corneas of the first 20 patients to undergo the procedure.

These results were compared with those from the mechanical keratome. Six patients had 6 months of follow-up and the remainder 3 months of follow-up.

He reported that the IntraLase implantation results in a greater decrease in spherical equivalent, better uncorrected visual acuity (UCVA) levels, and better best-corrected visual acuity (BCVA) compared with the mechanical method. Importantly, in none of the cases were the channels created too shallow. They also found that as the channels became narrower, the effect was greater.

"At 6 months after the IntraLase procedure to implant Intacs, the UCVA and BCVA levels were better than any results reported in the studies of the mechanical method, although the mechanical outcomes continued to improve to 12 month after implantation," Dr. Rabinowitz stated. "Further follow-up is needed to determine if the data are comparable 12 months after implantation. No explants were required. There is a high rate of patient satisfaction with the results at 6 months."

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
© 2025 MJH Life Sciences

All rights reserved.